Publication: Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
Issued Date
2011-07-05
Resource Type
ISSN
14752875
Other identifier(s)
2-s2.0-79959687225
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Malaria Journal. Vol.10, (2011)
Suggested Citation
Kris M. Jamsen, Stephen B. Duffull, Joel Tarning, Niklas Lindegardh, Nicholas White, Julie A. Simpson Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria. Malaria Journal. Vol.10, (2011). doi:10.1186/1475-2875-10-181 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/12025
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
Other Contributor(s)
Abstract
Background: Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are designed primarily by the logistical and ethical constraints of taking blood samples from patients, and the statistical models that are fitted to the data are not formally considered. This could lead to imprecise estimates of the target PK parameters, and/or designs insufficient to estimate all of the parameters. Optimal design methodology has been developed to determine blood sampling schedules that will yield precise parameter estimates within the practical constraints of sampling the study populations. In this work optimal design methods were used to determine sampling designs for typical future population PK studies of dihydroartemisinin, the principal biologically active metabolite of oral artesunate. Methods. Optimal designs were derived using freely available software and were based on appropriate structural PK models from an analysis of data or the literature and key sampling constraints identified in a questionnaire sent to active malaria researchers (3-4 samples per patient, at least 15 minutes between samples). The derived optimal designs were then evaluated via simulation-estimation. Results: The derived optimal sampling windows were 17 to 29 minutes, 30 to 57 minutes, 2.5 to 3.7 hours and 5.8 to 6.6 hours for non-pregnant adults; 16 to 29 minutes, 31 minutes to 1 hour, 2.0 to 3.4 hours and 5.5 to 6.6 hours for designs with non-pregnant adults and children and 35 to 59 minutes, 1.2 to 3.4 hours, 3.4 to 4.9 hours and 6.0 to 8.0 hours for pregnant women. The optimal designs resulted in acceptable precision of the PK parameters. Conclusions: The proposed sampling designs in this paper are robust and efficient and should be considered in future PK studies of oral artesunate where only three or four blood samples can be collected. © 2011 Jamsen et al; licensee BioMed Central Ltd.